Department of Surgery, Comprehensive Transplant Center, Ohio State University Medical Center, Columbus, OH 43210, USA.
J Immunol. 2010 Dec 15;185(12):7285-92. doi: 10.4049/jimmunol.1001655. Epub 2010 Nov 17.
We have previously reported that CD8(+) T cells significantly influence Ab production based on the observation that posttransplant alloantibody levels in CD8-deficient murine hepatocyte transplant recipients are markedly enhanced. However, the precise mechanisms contributing to enhanced alloantibody production in the absence of CD8(+) T cells is not understood. We hypothesized that alloactivated CD8(+) T cells inhibit Ab production by skewing toward a proinflammatory cytokine profile, whereas when these cells are absent, an anti-inflammatory cytokine profile shifts the alloimmune response toward alloantibody production. To investigate this possibility, alloantibody isotype profiles were examined in CD8-deficient and wild-type hepatocyte recipients. We found that IgG1 (IL-4-dependent isotype) was the dominant alloantibody isotype in wild-type recipients as well as in CD8-deficient recipients, although the amount of alloantibody in the latter group was substantially higher. Utilizing real-time PCR we found that CD4(+) T cells from wild-type recipients significantly upregulated IFN-γ but not IL-4 mRNA. In contrast, in the absence of CD8(+) T cells, CD4(+) T cells switched to significantly upregulate IL-4 mRNA, while IFN-γ was downregulated. IL-4 knockout mice do not produce any posttransplant alloantibody. However, adoptive transfer of wild-type CD4(+) T cells into CD8-depleted IL-4 knockout mice restores high alloantibody levels observed in CD8-depleted wild-type recipients. This suggests that IL-4-producing CD4(+) T cells are critical for posttransplant alloantibody production. Additionally, this CD8-mediated regulation of posttransplant alloantibody production is IFN-γ-dependent. Further elucidation of the mechanisms by which CD8(+) T cells influence Ab production will significantly contribute to development of therapies to manipulate humoral responses to Ag.
我们之前的研究表明,CD8+ T 细胞显著影响 Ab 产生,其依据是观察到 CD8 缺陷型鼠肝细胞移植受者的移植后同种抗体水平显著增强。然而,CD8+ T 细胞缺失时增强同种抗体产生的确切机制尚不清楚。我们假设,同种激活的 CD8+ T 细胞通过偏向促炎细胞因子谱来抑制 Ab 产生,而当这些细胞缺失时,抗炎细胞因子谱将同种免疫反应转向同种抗体产生。为了研究这种可能性,我们检查了 CD8 缺陷型和野生型肝细胞受者的同种抗体同种型谱。我们发现,IgG1(IL-4 依赖性同种型)是野生型受者以及 CD8 缺陷型受者中主要的同种抗体同种型,尽管后者群体中的同种抗体数量要高得多。利用实时 PCR,我们发现野生型受者的 CD4+ T 细胞显著上调 IFN-γ但不上调 IL-4 mRNA。相反,在缺乏 CD8+ T 细胞的情况下,CD4+ T 细胞转而显著上调 IL-4 mRNA,同时 IFN-γ下调。IL-4 基因敲除小鼠不产生任何移植后同种抗体。然而,将野生型 CD4+ T 细胞过继转移到 CD8 耗竭的 IL-4 基因敲除小鼠中,可恢复在 CD8 耗竭的野生型受者中观察到的高同种抗体水平。这表明产生 IL-4 的 CD4+ T 细胞对于移植后同种抗体产生至关重要。此外,这种 CD8 介导的移植后同种抗体产生的调节是 IFN-γ依赖性的。进一步阐明 CD8+ T 细胞影响 Ab 产生的机制将极大地促进开发用于操纵对 Ag 产生的体液反应的治疗方法。